Although inconclusive, available data suggest that more than a third of hospitalized COVID-19 patients develop lung fibrotic abnormalities after their discharge from hospital. Pulmonary fibrosis (PF), a pathological outcome of chronic and acute interstitial lung diseases associated to compromised wound healing, is a key component of the “post-acute COVID-19 syndrome” that may severely complicate patients’ clinical course. Web of Science - Science Citation Index Expanded.Web of Science - Science Citation Index.Web of Science - Prous Science Integrity.Web of Science - Current Contents/Life Sciences.Ulrich's Periodicals Directory/ulrichsweb.
#Clinical laboratory license verification series
Norwegian Register for Scientific Journals, Series and Publishers.KESLI-NDSL (Korean National Discovery for Science Leaders).Journal Citation Reports/Science Edition.Japan Science and Technology Agency (JST).CNKI Scholar (China National Knowledge Infrastructure).Chemical Abstracts Service (CAS) - SciFinder.Chemical Abstracts Service (CAS) - CAplus.Research Articles, Reviews, Mini Reviews and Opinion Papers on all aspects of clinical chemistry and laboratory medicine, Guidelines and Recommendations, Point/Counterpoint Articles, Letters to the Editor, EditorialsĬlinical Chemistry and Laboratory Medicine (CCLM) is covered by the following services: quality and safety in laboratory medicine.new reagents, instrumentation and technologies.disease-oriented topics (cardiovascular disease, cancer diagnostics, diabetes).clinical genomics and molecular biology.Letters to the Editor and Congress Abstracts are published online only. It is issued monthly, both in print and electronically. CCLM is led by a multi-institutional editorial board. All contributions submitted for publication in CCLM are single-blind peer reviewed by at least two experts in the field. CCLM is one of the leading journals in the field, with an impact factor over 3.5. It is focused on basic and applied research and cutting-edge clinical laboratory medicine. National Association Credential Evaluation Service, Inc.Clinical Chemistry and Laboratory Medicine ( CCLM) publishes articles on novel teaching and training methods applicable to laboratory medicine.High Complexity Testing: Laboratory Director Qualifications (pdf)ĬME Courses for Laboratory Directors of Moderate Complexity Laboratoriesįoreign academic credential evaluation may be performed by any nationally recognized organization (493.2(d).Delegation of director responsibilities (pdf).Certification Boards for Laboratory Directors of High Complexity Testing.Personnel Qualification Requirements - from another view (pdf).CMS Brochure: "What Do I Need to Do to Assess Personnel Competency?" (pdf).Personnel Qualification Requirements (pdf).Director Qualification Appraisal form (pdf) - To qualify Director, submit completed form with application.Table of CLIA Certificate fees (pdf) - Accredited and non-accredited CLIA laboratory fees.Information regarding submission of application (pdf).Labs NOT located in Oregon: Find your state agency and mail forms to them (pdf).You can verify receipt of your forms by calling 50 or by e-mailing Apply for a Certificate of Compliance or Certificate of Accreditation
Please don’t send hard copy following a fax or email of a lab form! Double forms can cause duplication and extra work. Complexity levels may be obtained from the manufacturer of laboratory reagents/kits or equipment. In addition, the Certificate of Compliance or Certificate of Accreditation authorizes a laboratory to perform only specific specialties and subspecialties for which the laboratory has been certified to perform.
A moderate complexity lab may perform all levels of testing up to and including moderate level tests. The Certificate of Compliance and Certificate of Accreditation authorizes a high complexity laboratory to perform all levels of testing.